네오이뮨텍

950220KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

1,715KRWMarket close of 10/20 (Tue)

Down -2.28%-40KRWMarket close of 10/20 (Tue)

Open: 1,786
High: 1,786
Low: 1,684
Day range: Day range low 1,684 high 1,786, open 1,786, close 1,715, previous close 1,755
Volume: 11×10K shares
: 180.06 million KRW 0.29× the 20-session average

Market close of 10/20 (Tue)

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

Earningsto check-14.48 million KRWOperating income over the last four quarters -14.48 million KRW (loss)Operating income, 8 quarters
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

Daily move-2.28%usual range
Trading value0.3×usual range
Data date10/20 (Tue)Market close

See the full check report

Key figures

: 58.7B KRW
: Not computed — loss-making, or the four quarters are incomplete
: 1,604.21×
: 34,211,840 shares
Trading value ratio: 0.29× the 20-session average0.3×

Financials filed 2026-10-02 · KRX·DART

Something to check

1 to check: operating loss

Earningsto checkQuarterly operating income bars (6); the four dark bars make up the sum-14.48 million KRW
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Daily moveusual range-2.28% on the reference date, placed against the usual ±2.46% band0.9×
Trading valueusual range0.29× the 20-session average0.3×
Data dateusual rangeMarket close data of 2026-10-20

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected

Revenue788,200 KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+4,383.8%
vs. prior quarter
+119.1%
Operating income-2.84 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
Still a loss
vs. prior quarter
Still a loss
Operating margin-359.8%Operating margin bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+26,748.2 pp
vs. prior quarter
+820.7 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-10-02

2021Q1 -9.67 million KRW2026Q2 -2.84 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock	20D	Change	Trading value
알테오젠	Close over the last 20 sessions -9.6%	Down -3.35%	51.1B KRW
올릭스	Close over the last 20 sessions -12.2%	Down -4.03%	19.1B KRW
디앤디파마텍	Close over the last 20 sessions -11.8%	Down -1.93%	15.1B KRW
리가켐바이오	Close over the last 20 sessions -15.4%	Down -1.41%	12.1B KRW
프로티나	Close over the last 20 sessions +31.8%	Up +7.38%	10.0B KRW

Schedule

Q3 report due · 11/16 (Mon) · in 26 days
Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.